Cormorant Asset Management’s Avidity Biosciences RNAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300,000	Closed	-$13.1M	–	43
2025 Q3	$13.1M	Buy	300,000 +100,000	+50%	+$4.04M	0.9%	26
2025 Q2	$5.68M	Sell	200,000 -200,000	-50%	-$5.96M	0.42%	37
2025 Q1	$11.8M	Sell	400,000 -650,000	-62%	-$20.2M	0.89%	27
2024 Q4	$30.5M	Hold	1,050,000	–	–	1.68%	17
2024 Q3	$48.2M	Buy	1,050,000 +625,000	+147%	+$27.1M	2.56%	11
2024 Q2	$17.4M	Buy	+425,000	New	+$12.2M	1.01%	30
2023 Q4	–	Sell	-1,762,115	Closed	-$11.2M	–	55
2023 Q3	$11.2M	Sell	1,762,115 -850,000	-33%	-$7.32M	0.66%	33
2023 Q2	$29M	Hold	2,612,115	–	–	1.65%	15
2023 Q1	$40.1M	Sell	2,612,115 -150,000	-5%	-$3.3M	2.64%	10
2022 Q4	$61.3M	Buy	2,762,115 +750,000	+37%	+$11.2M	4.12%	5
2022 Q3	$32.9M	Hold	2,012,115	–	–	2.31%	14
2022 Q2	$29.2M	Hold	2,012,115	–	–	2.27%	13
2022 Q1	$37.2M	Hold	2,012,115	–	–	2.85%	11
2021 Q4	$47.8M	Sell	2,012,115 -150,000	-7%	-$3.58M	2.84%	10
2021 Q3	$53.3M	Sell	2,162,115 -66,552	-3%	-$1.45M	2.16%	14
2021 Q2	$55.1M	Sell	2,228,667 -235,878	-10%	-$5.49M	2.15%	14
2021 Q1	$53.8M	Sell	2,464,545 -2	-0%	-$49	1.55%	21
2020 Q4	$62.9M	Sell	2,464,547 -49,999	-2%	-$1.46M	1.83%	23
2020 Q3	$69.5M	Sell	2,514,546 -1	-0%	-$29	3.06%	8
2020 Q2	$67.8M	Buy	+2,514,547	New	+$72.5M	2.97%	10